Copeia

Copeia is a German technology innovator founded in 2020 that develops AI- and data-based solutions to optimize cannabis-based healthcare. We support both patients and the healthcare industry—doctors, pharmacies, pharma companies, health insurers—to drive improvements in treatment cost and quality, innovation, and outcomes. Copeia's platform and data-rich ecosystem, engineered by a multidisciplinary team with deep healthcare experience, provide a single touchpoint for understanding, applying, and reporting on cannabis therapies. We operate across domains and applications, to unlock an experience that is less complex, steadier and safer. Doctors have been challenged to prescribe medical cannabis, even when it represents a patient's best treatment option, due to the lack of integration of cannabis-based therapies into existing healthcare processes. Workflows are constrained by cumbersome administrative protocols, evolving healthcare regulations, and complex insurance claims procedures. Everyday, Copeia: • Educates patients about available cannabis-involved therapies • Helps physicians contextualize cannabis therapies with patient needs • Provides an actionable understanding of relevant healthcare regulations & cannabis therapy availability • Streamlines workflows for administrators, pharmacies, pharma companies & insurers Copeia is currently exclusive to the healthcare market in Germany. However, we are in the process of expanding to other EU markets, with support for additional therapeutic modalities. Extreme collaboration is the future of healthcare. Copeia is helping everyone reimagine an approach that is smarter, more interconnected, and better.